Abstract
Purpose
To evaluate the safety, technical success and short-term effectiveness of polyurethane-covered stent (PK Papyrus, BioTronik, Berlin) in the treatment of pulmonary arteriovenous malformations (PAVMs) that are not amenable to embolotherapy.
Materials and Methods
In this IRB-approved, retrospective study, data from patients who received polyurethane-covered stents for exclusion of PAVMs were analyzed. The study included 5 patients (all women) with a median age of 40 years (range 25–60). Patients presented with hypoxemia, TIAs, and/or epistaxis; 4 were confirmed to have HHT. All had multiple PAVMs diagnosed on chest CT and underwent embolization with other devices in addition to the polyurethane-covered stent. The indication for stent placement in all cases was a short and/or tortuous feeding artery. Safety was assessed by immediate or short-term complications, e.g., migration, stent thrombosis, and fracture. Technical success was defined as the ability to accurately place the stent at the intended location. Effectiveness was defined as successful exclusion of PAVM with no perfusion across the AVM.
Results
Technical success of stent placement was 100%. AVM exclusion rate was 80% after single stent deployment; in the case of incomplete exclusion, success was achieved using an overlapping stent to completely cover a second feeding artery. During the median follow-up period of 5 months (range 2–10), all stents remained patent, and AVMs were excluded without other complications.
Conclusion
Exclusion of PAVMs with polyurethane-covered stents is technically feasible, safe, and shows short-term effectiveness for PAVMs with a short/tortuous feeding artery when traditional embolization techniques are not possible.
Graphical Abstract
References
Gossage JR, Kanj G. Pulmonary arteriovenous malformations: a state of the art review. Am J Respir Crit Care Med. 1998;158:643–61.
Pollak J, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations clinical studies. J Vasc Interv Radiol. 2006;17(1):35–45.
Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology. 2000;55(7):959–64. https://doi.org/10.1212/WNL.55.7.959.
Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173(12):989–1001. https://doi.org/10.7326/M20-1443.
Mager JJ, Overtoom TTC, Blauw H, Lammers JWJ, Westermann CJJ. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol. 2004;15(5):451–6. https://doi.org/10.1097/01.RVI.0000126811.05229.B6.
Tellapuri S, Park HS, Kalva SP. Pulmonary arteriovenous malformations. Int J Cardiovasc Imaging. 2019;35(8):1421–8. https://doi.org/10.1007/s10554-018-1479-x.
Burke CM, Safai C, Nelson DP, Raffin TA. Pulmonary arteriovenous malformations: a critical update. Am Rev Respir Dis. 1986;134(2):334–9. https://doi.org/10.1164/arrd.1986.134.2.334.
Trerotola SO, Pyeritz RE, Bernhardt BA. Outpatient single-session pulmonary arteriovenous malformation embolization. J Vasc Interv Radiol. 2009;20(10):1287–91. https://doi.org/10.1016/j.jvir.2009.06.026.
Latif MA, Bailey CR, Motaghi M, et al. Postembolization persistence of pulmonary arteriovenous malformations: a retrospective comparison of coils and amplatzer and micro vascular plugs using propensity score weighting. Am J Roentgenol. 2023;220(1):95–103. https://doi.org/10.2214/AJR.21.27218.
Trerotola SO, Pyeritz RE. PAVM embolization: an update. Am J Roentgenol. 2010;195(4):837–45. https://doi.org/10.2214/AJR.10.5230.
Fidelman N, Gordon RL, Bloom AI, LaBerge JM, Kerlan RK. Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs. J Vasc Interv Radiol. 2008;19(8):1246–50. https://doi.org/10.1016/j.jvir.2008.05.001.
Trerotola SO, Pyeritz RE. Does use of coils in addition to amplatzer vascular plugs prevent recanalization? Am J Roentgenol. 2010;195(3):766–71. https://doi.org/10.2214/AJR.09.3953.
Bailey CR, Arun A, Towsley M, et al. MVP™ micro vascular plug systems for the treatment of pulmonary arteriovenous malformations. Cardiovasc Intervent Radiol. 2019;42(3):389–95. https://doi.org/10.1007/s00270-018-2106-x.
Mahdjoub E, Tavolaro S, Parrot A, Cornelis F, Khalil A, Carette MF. Pulmonary arteriovenous malformations: safety and efficacy of microvascular plugs. Am J Roentgenol. 2018;211(5):1135–43. https://doi.org/10.2214/AJR.17.19200.
Ratnani R, Sutphin PD, Koshti V, et al. Retrospective comparison of pulmonary arteriovenous malformation embolization with the polytetrafluoroethylene-covered nitinol microvascular plug, AMPLATZER plug, and coils in patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol. 2019;30(7):1089–97. https://doi.org/10.1016/j.jvir.2019.02.025.
Meek M, Meek J, Beheshti M. Management of pulmonary arteriovenous malformations. Semin Interv Radiol. 2011;28(01):024–31. https://doi.org/10.1055/s-0031-1273937.
Bai HX, Pyeritz RE, Trerotola SO. Covered stents in the treatment of pulmonary arteriovenous malformations. J Vasc Interv Radiol. 2018;29(7):981–5. https://doi.org/10.1016/j.jvir.2017.12.024.
Trerotola SO, Pyeritz RE. Covered stent to treat pulmonary arteriovenous malformation with short feeding artery. J Vasc Interv Radiol. 2009;20(6):824–8. https://doi.org/10.1016/j.jvir.2009.03.001.
Woodward CS, Pyeritz RE, Chittams JL, Trerotola SO. Treated pulmonary arteriovenous malformations: patterns of persistence and associated retreatment success. Radiology. 2013;269(3):919–26.
Jurado-Román A, Rodríguez O, Amat I, et al. Clinical outcomes after implantation of polyurethane-covered cobalt-chromium stents: insights from the papyrus-spain registry. Cardiovasc Revasc Med. 2021;29:22–8. https://doi.org/10.1016/j.carrev.2020.08.017.
Kandzari DE, Birkemeyer R. PK Papyrus covered stent: device description and early experience for the treatment of coronary artery perforations. Catheter Cardiovasc Interv. 2019;94(4):564–8. https://doi.org/10.1002/ccd.28306.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
For this type of study, formal consent is not required.
Consent for Publication
For this type of study, consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Adams, R.C., Hegde, S., Sutphin, P. et al. Use of Polyurethane-Covered Stents for Exclusion of Pulmonary Arteriovenous Malformations. Cardiovasc Intervent Radiol 47, 360–365 (2024). https://doi.org/10.1007/s00270-023-03638-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03638-0